Taking inspiration from the natural world to create efficient and elegant solutions to engineering challenges has become a popular process, and IP is often the key to the successful development and commercialisation of this technology.
HGF’s biomimetics IP team advises organisations involved in all stages of biomimetic engineering, providing tailored advice from the conception phase, where the final use might not yet be clear, through to commercialisation.
The team’s experience and unique mix of academic, technical, and legal backgrounds, across life sciences and engineering, allows for the crafting and implementation of an IP strategy that matches a client’s particular requirements, be that licensing the technology, product development, or commercialisation.
With particular expertise in biomimetic technology for aerospace, manufacturing, sensors and robotics, HGF works with academic institutions and businesses to create bespoke IP strategies, secure IP protection, perform landscaping or clearance searches, provide due diligence advice for licensing, and advise companies on IP strategies to enhance their business plan.
IAM Patent 1000 the world’s leading patent professionals 2023 guide has now been published and we are delighted to have 31 attorneys recognised as world-class individuals in the guide. The …Read article
Innovative businesses should seek to maximise the value they obtain from working collaboratively within a product platform ecosystem. A well-defined IP strategy can help achieve this while increasing total innovation …Read article
HGF will be exhibiting at The North East Automotive Alliance’s flagship Expo on 29th September 2022. The event is an industry highlight for companies operating within the region’s automotive supply …Event details
Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …Read article
HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …Event details
When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …Read article
Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …Read article
It is now eight years since the first lab-grown burger was unveiled by a team of scientists at Maastricht University, but since then the path to market has been slow. …Read article